The slow trickle downtrend continues. It's a little concerning knowing that radiogel is close to hitting the market and there is no interest in the stock. Hopefully it holds at the .17 mark. We shall see. We really need some better news.
It is my interpretation that you do not understand the approval. I already voice my opinion and EVERYONE got #$%$ but here it is.
The aproval that is before the FDA is not for commercial use. Animal studies are not the human studies which are needed for use in humans everyday at our cancer centers in the Northwest.
They are not building a facility until isotope sales are much better.
The stock is well supported by the ownership of the company.
The stock is not going to blow up to $1.00 or $.30 anytime soon. If you want to trade it then MAYBE you can get lucky several times. The stock is actively speculative.
Resistance was $.18 and it was broken. Look at the averages and make a call. I am a buyer at levels to the downside but I am long this stock. If you have your first investment here then you made a mistake. I you are to exposed then you have made mistakes.
The stock is right where it should be. Management knows it and the market knows it.
They said they expect Radiogel to hit the market this year. If they still had to do human testing, there is no way that could happen. I don't think they have to go through the vigorous testing that most pharma's need to go through. If they do, then they would be lying to the shareholders , and that definitely is not a good thing.